Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Chronic Phase Chronic Myeloid Leukemia
View Full LandscapeTarget Indication
Chronic Phase Chronic Myeloid Leukemia
Clinical Trial
NCT01593254Last updated: 8/16/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
COVID-19
Macular Neovascularization Secondary to Age-Related Macular Degeneration
Multiple Myeloma in Relapse
Leukemia
Large Cell Neuroendocrine Carcinoma